Vanguard Portfolio Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.53B Buy
4,130,135
+114,369
+3% +$40.4M 0.07% 311
2026
Q2
$1.44B Sell
4,015,766
-78,243
-2% -$23.9M 0.07% 340
2026
Q1
$1.03B Buy
+4,094,009
New +$1.02B 0.05% 401

Other funds holding WST

Vanguard Portfolio Management's WST Position: Q3 2026 in Review

Vanguard Portfolio Management increased its West Pharmaceutical (WST) stake by 2.8% in Q3 2026, buying an estimated $40.4M and bringing the position to 4,130,135 shares worth $1.53B. The position accounts for 0.07% of the portfolio, ranked #311.

Vanguard Portfolio Management first reported a position in WST in Q1 2026 and has held it in 3 quarters since. 881 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Vanguard Portfolio Management held 4,130,135 shares of West Pharmaceutical worth $1.53B as of Q3 2026.
  • Vanguard Portfolio Management bought 114,369 West Pharmaceutical shares in Q3 2026, an estimated $40.4M.
  • West Pharmaceutical made up 0.07% of Vanguard Portfolio Management's portfolio in Q3 2026, its #311 holding.
  • Vanguard Portfolio Management first reported a position in West Pharmaceutical in Q1 2026 and has held it in 3 quarters since.
  • 881 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.